Stefania Salvi

Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.

Andrea Anichini, C Maccalli, Roberta Mortarini et al. · The Journal of Experimental Medicine · 1993 · 170 citations · Full text

Histocompatibility, Hla Immunogenetics, Immunology +17

Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1.

Marialuisa Sensi, Catia Traversari, Marina Radrizzani et al. · Proceedings of the National Academy of Sciences · 1995 · 102 citations · Full text

Histocompatibility, Hla, T-regulatory Cell +20

T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.

Marialuisa Sensi, Stefania Salvi, Chiara Castelli et al. · The Journal of Experimental Medicine · 1993 · 97 citations · Full text

Overexpression of the T-cell receptor beta-chain variable region TCRBV14 in HLA-A2-matched primary human melanomas.

Stefania Salvi, Fabio Segalla, Shyam Rao et al. · PubMed · 1995 · 42 citations

Primary Melanomas, Cancer Immunosurveillance, Melanoma +15

High frequency of T cell clonal expansions in primary human melanoma. Involvement of a dominant clonotype in autologous tumor recognition

Patrizia Pisarra, Roberta Mortarini, Stefania Salvi et al. · Cancer Immunology Immunotherapy · 1999 · 18 citations · Full text

Tumor Biology, Health Sciences, Skin Cancer +10